Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Schlumberger NV — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Schlumberger NV trades at $48.59 (market cap $72.00B). The key difference: Schlumberger NV is far larger — about 10.1× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Schlumberger NV pays a 2.43% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Schlumberger NV for 99 Days on average.
| IONS | SLB | |
|---|---|---|
Market Cap | $7.10B | $72.00B |
Volume | 2,027,457 | 9,844,196 |
Sector | Health | Energy |
52-Week High | $86.50 | $60.10 |
52-Week Low | $42.38 | $32.57 |
Typical Hold Time | 0 Days | 99 Days |
Enterprise Value | $6.66B | $80.72B |
Dividend Yield | — | 2.43% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SLB trades at $48.77, showing stable performance with no recent price movement. The stock demonstrates strong fundamental metrics including a 23.79 P/E ratio and 8.53% net income margin, supported by consistent earnings beats in recent quarters. Recent contract wins in Saudi Arabia, Oman, and Mozambique expand the company's international footprint and revenue visibility. Technical indicators show bearish momentum with the price near key support levels at $48.
SLB presents a compelling investment case with strong analyst support (84.85% buy rating) and a $64.58 consensus price target representing 32% upside potential. However, declining profit margins from 12.68% in 2023 to 8.52% projected for 2026 and bearish technical signals warrant caution. The company's expanding contract portfolio provides revenue stability, but investors should monitor margin pressures and oil market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
